Synopsys Net Worth
Synopsys Net Worth Breakdown | SNPS |
Synopsys Net Worth Analysis
Synopsys' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Synopsys' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Synopsys' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Synopsys' net worth analysis. One common approach is to calculate Synopsys' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Synopsys' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Synopsys' net worth. This approach calculates the present value of Synopsys' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Synopsys' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Synopsys' net worth. This involves comparing Synopsys' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Synopsys' net worth relative to its peers.
Enterprise Value |
|
To determine if Synopsys is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Synopsys' net worth research are outlined below:
| Over 94.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: COMPUTEX 2024 Forum Sets the Stage as Tech Titans Gather to Witness Next-Gen AI Developments |
Synopsys Quarterly Good Will |
|
Synopsys uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Synopsys. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Synopsys' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 21st of February 2024 Upcoming Quarterly Report | View | |
| 15th of May 2024 Next Financial Report | View | |
| 31st of January 2024 Next Fiscal Quarter End | View | |
| 4th of December 2024 Next Fiscal Year End | View | |
| 31st of October 2023 Last Quarter Report | View | |
| 31st of October 2023 Last Financial Announcement | View |
Know Synopsys' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Synopsys is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Synopsys backward and forwards among themselves. Synopsys' institutional investor refers to the entity that pools money to purchase Synopsys' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Nuveen Asset Management, Llc | 2023-12-31 | 2.5 M | Norges Bank | 2023-12-31 | 2.5 M | Ameriprise Financial Inc | 2023-12-31 | 1.8 M | Amvescap Plc. | 2023-12-31 | 1.8 M | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1.7 M | Northern Trust Corp | 2023-12-31 | 1.6 M | Legal & General Group Plc | 2023-12-31 | 1.4 M | Amundi | 2023-12-31 | 1.3 M | Alliancebernstein L.p. | 2023-12-31 | 1.3 M | Vanguard Group Inc | 2023-12-31 | 13.6 M | Blackrock Inc | 2023-12-31 | 11.8 M |
Follow Synopsys' market capitalization trends
The company currently falls under 'Large-Cap' category with a current market capitalization of 85.37 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Synopsys's market, we take the total number of its shares issued and multiply it by Synopsys's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Market Cap |
|
Project Synopsys' profitablity
Synopsys' profitability indicators refer to fundamental financial ratios that showcase Synopsys' ability to generate income relative to its revenue or operating costs. If, let's say, Synopsys is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Synopsys' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Synopsys' profitability requires more research than a typical breakdown of Synopsys' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.19 | 0.20 | |
| Return On Capital Employed | 0.20 | 0.15 | |
| Return On Assets | 0.14 | 0.08 | |
| Return On Equity | 0.23 | 0.12 |
When accessing Synopsys' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Synopsys' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Synopsys' profitability and make more informed investment decisions.
The data published in Synopsys' official financial statements usually reflect Synopsys' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Synopsys. For example, before you start analyzing numbers published by Synopsys accountants, it's critical to develop an understanding of what Synopsys' liquidity, profitability, and earnings quality are in the context of the Software space in which it operates.
Please note, the presentation of Synopsys' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Synopsys' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Synopsys' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Synopsys. Please utilize our Beneish M Score to check the likelihood of Synopsys' management manipulating its earnings.
Evaluate Synopsys' management efficiency
Synopsys has return on total asset (ROA) of 0.0875 % which means that it generated a profit of $0.0875 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2254 %, meaning that it created $0.2254 on every $100 dollars invested by stockholders. Synopsys' management efficiency ratios could be used to measure how well Synopsys manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.20 in 2024, whereas Return On Capital Employed is likely to drop 0.15 in 2024. At this time, Synopsys' Fixed Asset Turnover is comparatively stable compared to the past year. Asset Turnover is likely to gain to 0.67 in 2024, whereas Deferred Long Term Asset Charges is likely to drop slightly above 313 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 36.36 | 38.18 | |
| Net Current Asset Value | 0.00 | 0.00 | |
| Tangible Asset Value | 0.00 | 0.00 | |
| Tangible Book Value Per Share | 10.29 | 10.81 | |
| Enterprise Value Over EBITDA | 38.08 | 39.98 | |
| Price Book Value Ratio | 13.36 | 14.03 | |
| Enterprise Value Multiple | 38.08 | 39.98 | |
| Price Fair Value | 13.36 | 14.03 | |
| Enterprise Value | 44.6 B | 46.9 B |
The analysis of Synopsys' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Synopsys' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Synopsys Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Enterprise Value Revenue 13.7652 | Revenue 6.1 B | Quarterly Revenue Growth 0.211 | Revenue Per Share 40.3 | Return On Equity 0.2254 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Synopsys insiders, such as employees or executives, is commonly permitted as long as it does not rely on Synopsys' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Synopsys insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Roy Vallee over six months ago Exercise or conversion by Roy Vallee of 6666 shares of Synopsys subject to Rule 16b-3 | ||
Roy Vallee over a year ago Acquisition by Roy Vallee of 464 shares of Synopsys subject to Rule 16b-3 |
Synopsys Corporate Filings
| 13th of May 2024 Other Reports | ViewVerify | |
8K | 6th of May 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 17th of April 2024 Other Reports | ViewVerify | |
F4 | 12th of April 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Synopsys Earnings per Share Projection vs Actual
Be your own money manager
Our tools can tell you how much better you can do entering a position in Synopsys without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
Synopsys Corporate Management
Elected by the shareholders, the Synopsys' board of directors comprises two types of representatives: Synopsys inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Synopsys. The board's role is to monitor Synopsys' management team and ensure that shareholders' interests are well served. Synopsys' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Synopsys' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joseph Logan | Executive VP of Sales and Corporate Marketing | Profile | |
| Paul Stravers | Principal Engineer | Profile | |
| Shelagh Glaser | Chief Officer | Profile | |
| Charlie Matar | Senior Group | Profile | |
| John Koeter | Senior Strategy | Profile | |
| John Runkel | General Counsel and Corporate Secretary | Profile |
How to buy Synopsys Stock?
The net worth of Synopsys is the difference between its total assets and liabilities. Synopsys' net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Synopsys' assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Synopsys' net worth can be used as a measure of its financial health and stability which can help investors to decide if Synopsys is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Synopsys stock.Already Invested in Synopsys?
The danger of trading Synopsys is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Synopsys is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Synopsys. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Synopsys is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Synopsys is a strong investment it is important to analyze Synopsys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Synopsys' future performance. For an informed investment choice regarding Synopsys Stock, refer to the following important reports: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Synopsys. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Synopsys Stock please use our How to Invest in Synopsys guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Synopsys Stock analysis
When running Synopsys' price analysis, check to measure Synopsys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synopsys is operating at the current time. Most of Synopsys' value examination focuses on studying past and present price action to predict the probability of Synopsys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synopsys' price. Additionally, you may evaluate how the addition of Synopsys to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| CEOs Directory Screen CEOs from public companies around the world |
Is Synopsys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Synopsys. If investors know Synopsys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Synopsys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.651 | Earnings Share 9.09 | Revenue Per Share 40.3 | Quarterly Revenue Growth 0.211 | Return On Assets 0.0875 |
The market value of Synopsys is measured differently than its book value, which is the value of Synopsys that is recorded on the company's balance sheet. Investors also form their own opinion of Synopsys' value that differs from its market value or its book value, called intrinsic value, which is Synopsys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Synopsys' market value can be influenced by many factors that don't directly affect Synopsys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Synopsys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Synopsys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Synopsys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.